Terns Pharmaceuticals, Inc.
TERN
$52.63
$0.070.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.02B | 295.64M | 315.45M | 334.26M | 358.16M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.21M | 4.66M | 3.51M | 3.48M | 3.95M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.02B | 300.30M | 318.95M | 337.75M | 362.11M |
|
|
|||||
| Total Current Assets | 1.02B | 300.30M | 318.95M | 337.75M | 362.11M |
| Net Property, Plant & Equipment | 884.00K | 997.00K | 1.11M | 1.22M | 1.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 359.00K | 356.00K | 351.00K | 350.00K |
| Total Assets | 1.03B | 301.65M | 320.42M | 339.32M | 363.93M |
|
|
|||||
| Total Accounts Payable | 1.72M | 2.95M | 2.85M | 2.78M | 2.15M |
| Total Accrued Expenses | 13.77M | 11.04M | 9.16M | 7.15M | 12.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 474.00K | 459.00K | 444.00K | 429.00K | 428.00K |
| Total Finance Division Other Current Liabilities | 449.00K | 940.00K | 461.00K | 580.00K | 455.00K |
| Total Other Current Liabilities | 449.00K | 940.00K | 461.00K | 580.00K | 455.00K |
| Total Current Liabilities | 16.41M | 15.39M | 12.91M | 10.94M | 15.65M |
|
|
|||||
| Total Current Liabilities | 16.41M | 15.39M | 12.91M | 10.94M | 15.65M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 445.00K | 570.00K | 689.00K | 806.00K | 919.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.70M | 1.63M | 1.58M | 1.53M | 1.49M |
| Total Liabilities | 18.55M | 17.59M | 15.19M | 13.27M | 18.06M |
|
|
|||||
| Common Stock & APIC | 1.52B | 778.07M | 774.73M | 771.38M | 767.63M |
| Retained Earnings | -517.69M | -494.12M | -469.48M | -445.39M | -421.48M |
| Treasury Stock & Other | 260.00K | 109.00K | -22.00K | 51.00K | -279.00K |
| Total Common Equity | 1.01B | 284.07M | 305.23M | 326.04M | 345.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.01B | 284.07M | 305.23M | 326.04M | 345.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.01B | 284.07M | 305.23M | 326.04M | 345.87M |
|
|
|||||